Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06119425 · ClinicalTrials.gov registry record · NA
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
A NA study, sponsored by Ballad Health.
- Completed
- Registry status
- NA
- Development phase
- 231
- Enrollment target
NCT06119425: Completed NA study, sponsored by Ballad Health.
NCT06119425 is a NA study that has completed, run by Ballad Health. The registered enrollment target is 231 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06119425, a NA study, has completed, sponsored by Ballad Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
Study Summary
This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening.
Primary Outcome
Number of participants who agree to be screened CRC. % of participants who agree to be screened for CRC.
Interventions
- DIAGNOSTIC_TEST blood-based CRC screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2023-10-12 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the finished NCT06119425 record still lists
NCT06119425 is an interventional study that assigns participants to a tested intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which blood-based CRC screening is the first listed.
NCT06119425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06119425 about?
NCT06119425 is a clinical study titled "Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands". This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening t...
What is the current status of trial NCT06119425?
This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2023-10-12. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06119425?
The interventions under investigation include: blood-based CRC screening (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06119425?
This trial is sponsored by Ballad Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06119425's enrollment target sits among peer trials
231 465th of 2000 higher than 1,536 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT05019495 · 231 participants · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI